ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2023

Should Joint Ultrasound Contribute to Therapeutic Decisions in Juvenile Idiopathic Arthritis?

Marie Halbwachs1, Geraldine Durand2, Caroline Robin1, Catherine Gambert Abdel Rahman1, Pierre Ingrand3 and Elisabeth Solau-Gervais2, 1Paediatric, University Hospital, Poitiers, France, 2Rheumatology, University Hospital, Poitiers, France, 3Inserm, CIC-P 802, University Hospital, Poitiers, France

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Juvenile idiopathic arthritis (JIA) and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Over several years, numerous studies have been published on the interest of joint ultrasound in juvenile idiopathic arthritis. Several authors have demonstrated that ultrasonography is more sensitive in synovitis detection than clinical examination. As of today, we do not know whether or not joint ultrasonography has an impact on therapeutic decisions. The objective of this study is to determine the interest of joint ultrasonography in therapeutic management of juvenile idiopathic arthritis.

Methods:

This was a monocentric, open cross-sectional study, conducted on twenty-seven outpatients with JIA between March 2010 and January 2012. Ultrasound (US) evaluations were always carried out by the same rheumatologist, who had been trained in joint US. The ultrasound scanner was an EsaoteMylab 60. The wrists, hands and feet were systematically analysed, as was any painful joint. Therapeutic decisions were taken following clinical examination and joint ultrasound. In the second step of the study, all of the consultations with ultrasound evaluation were summarized in the form of scenarios and submitted to clinicians, without the US results. Three physicians then expressed their therapeutic decisions (no modification, treatment enhancement or reduced treatment), which were subsequently compared with and without ultrasound data.

Results:

Among the twenty-seven children followed, US was carried out in thirteen. 53.8% of the thirteen children had oligoarticular JIA and the other 46.2% had polyarticular onset. Between March 2010 and January 2012, 34 ultrasounds were carried out on thirteen children and thirty-four scenarios were elaborated. Subclinical synovitis was found in 94.1% of the US with a mean of 4.82+/-3.46. Treatment enhancement ensued after 52.8% of the consultations with ultrasound evaluation, with a mean subclinical synovitis of 5.11+/- 3.31. Divergent decisions (29.4%) were found when comparing consultation with ultrasound and scenario without ultrasound. Whether there were more than 2 clinical instances of synovitis or none, the decision remained similar. The divergent decisions came about either when children were symptomatic but with no more than two clinical instances of arthritis or asymptomatic with no clinical synovitis.

Conclusion:

This study strongly confirms the interest of joint ultrasound in therapeutic decision-making. It establishes a usable therapeutic tool by means of accurate articular evaluation and suggests its interest in the therapeutic management of JIA children, especially when the clinical data are not sufficiently explicit.


Disclosure:

M. Halbwachs,
None;

G. Durand,
None;

C. Robin,
None;

C. Gambert Abdel Rahman,
None;

P. Ingrand,
None;

E. Solau-Gervais,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/should-joint-ultrasound-contribute-to-therapeutic-decisions-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology